Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
1.
Kyobu Geka ; 63(1): 57-64, 2010 Jan.
Article in Japanese | MEDLINE | ID: mdl-20077834

ABSTRACT

Invading apical lung cancers are generally the non-small-cell lung cancers (NSCLCs) which involve the apex of the chest wall. These tumors should be classified into 2 types based on the main location of tumor because of the difference of involved surrounding structures ; (1) the superior sulcus tumor origi nally termed Pancoast tumor which involves posterior region of the apex and (2) the anterior apical tumor which involves anterior region of the apex. Previously, these NSCLCs were considered to be inoperable showing a dismal prognosis. With the development of combined modality therapies for locally advanced NSCLCs, the prognosis of invading apical NSCLCs has been improved, especially since intro duction of the neoadjuvant chemoradiotherapy. Surgical resection for invading apical NSCLCs is 1 of challenging procedures for thoracic surgeons. The point is the anatomical complication of the small apex surrounding vital structures. Several approaches have been developed such as the posterior Paul-son's approach or anterior Masaoka's approach. In particular, the approach from anterior chest has been modified or devised to achieve safe and complete resection of tumors invading anterior structures like subclavian vessels. In this article, we reviewed our 13 cases of invading apical NSCLCs, especially from the view point of surgical approach. Thoracic surgeons should understand the properties of each approach and master them for complete resection avoiding serious complications.


Subject(s)
Lung Neoplasms/surgery , Pancoast Syndrome/surgery , Adult , Female , Humans , Male , Middle Aged , Thoracic Surgical Procedures/methods
2.
Kyobu Geka ; 61(1): 31-5, 2008 Jan.
Article in Japanese | MEDLINE | ID: mdl-18186270

ABSTRACT

Retrospective analysis was done to evaluate concurrent chemoradiotherapy (CCRT) using chemotherapeutic agents judged to be sensitive by histoculture drug response assay (HDRA) for non-small cell lung cancer (NSCLC). We treated 21 NSCLC patients with CCRT using senstivie agents judged by HDRA from 1999 to 2004. Objective response was evaluated in 20 patients. They were consisted of 1 complete response (CR) case, 18 partial response (PR) cases, and 1 stable disease (SD) case. The response rate was 95%. Ten cancer related deaths were observed during 816 +/- 861 (60-2,780) days follow-up. Median survival time was 604 days. One- and 5-year survival rates were 73.9% and 40.3%, respectively. In conclusion, HDRA may improve efficacy of CCRT for NSCLC.


Subject(s)
Carcinoma, Non-Small-Cell Lung/therapy , Drug Screening Assays, Antitumor , Aged , Combined Modality Therapy , Female , Humans , Male , Middle Aged , Treatment Outcome
3.
Kyobu Geka ; 59(11): 980-4, 2006 Oct.
Article in Japanese | MEDLINE | ID: mdl-17058658

ABSTRACT

The experience of 14 cases with surgical stabilization of multiple rib fracture and flail chest was reported. They were 11 men and 3 women of 31 to 87 years of age. Paradoxical chest movement was noted in 10 patients. Thirteen of 14 patients successfully weaned from the ventilator less than 7 days after surgery. Of 14, 4 cases were treated with internal fixation and the others were with acetabular reconstruction plates with or without rib stapler. No case of death was experienced. Ten patients who were performed fixation with acetabular reconstruction plate weaned from the ventilator earlier than cases treated by internal fixation, suggesting the superiority of the acetabular reconstruction plate. Improvement of rib stapler and the development of a titanium plate of specific use for rib is expected in the future.


Subject(s)
Rib Fractures/surgery , Adult , Aged , Aged, 80 and over , Female , Flail Chest/etiology , Flail Chest/surgery , Fracture Fixation, Internal/methods , Humans , Male , Middle Aged , Orthopedic Fixation Devices
4.
Br J Dermatol ; 155(2): 437-45, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16882186

ABSTRACT

BACKGROUND: Irreversible, permanent and scarring alopecia is associated with several autoimmune diseases, including all autoimmune connective tissue disorders. The pathogenesis of autoimmune-induced permanent alopecia (APA) is still poorly understood, and instructive, simple mouse models for the study of APA are needed urgently. During the course of our studies in a well-established mouse model for chronic rheumatoid arthritis, the New Zealand Black/KN (NZB/KN) mouse, we noticed that ageing male NZB/KN mice developed spontaneous APA. OBJECTIVES: To study whether alopecia seen in ageing male NZB/KN mice displays key features of human APA and may, thus, be a useful new mouse model for clinically relevant APA research. METHODS: NZB/KN, the F1 hybrid of NZW/N Slc x NZB/KN (W/BKN F1), the F1 hybrid of NZB/KN x NZW/N Slc (BKN/W F1), and the F2 hybrid of W/BKN F1 x W/BKN F1 mice were employed in this study, in order to check which strain carries the highest risk of alopecia development. Besides routine histology, CD3, CD4 and CD8 expression as well as immunoglobulin (Ig) G and IgM deposition in hair follicles were investigated by immunohistology/immunofluorescence. Mast cell distribution/degranulation and Ki-67 (proliferation)/TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling) (apoptosis) positive cells were also analysed. RESULTS: Only F2 male NZB/KN mice were prone to develop alopecia, suggesting that Y chromosome-associated gene(s) are involved in the pathogenesis of APA, which incidence rises with increasing age. The lesional alopecia skin in 12-month-old male NZB/KN mice showed a sharp decline in hair follicle density, thus meeting a key criterion of permanent alopecia. Both macroscopically and histologically, the alopecia seen in these mice resembled in many respects different stages of clinical APA, such as alopecia associated with chronic discoid lupus erythematosus (DLE) in humans. Lesional APA hair follicles in mice displayed intrafollicular and perifollicular mononuclear cell infiltrates, as well as an increased number of activated (degranulated) perifollicular mast cells. In the fully developed lesion, many CD4+ cells were seen in perifollicular locations, including the epithelial stem cell region (bulge), and also contained a few CD8+ T cells. IgM deposits were found in the follicular basement membrane zone (BMZ). Both in the bulge and the hair matrix region of the affected anagen hair follicles, there were signs of massive keratinocyte apoptosis. CONCLUSIONS: Our currently available data suggest that male but not female NZB/KN mice may indeed represent a suitable mouse model for APA, with some similarities to the permanent alopecia seen in human DLE patients, although additional and confirmatory investigations are needed before this mouse strain can be accepted as a murine equivalent of APA in humans.


Subject(s)
Alopecia/immunology , Autoimmune Diseases/immunology , Disease Models, Animal , Mice, Inbred NZB , Aging/immunology , Aging/pathology , Alopecia/genetics , Alopecia/pathology , Animals , Autoimmune Diseases/genetics , Autoimmune Diseases/pathology , Basement Membrane/immunology , Female , Fluorescent Antibody Technique, Direct , Fluorescent Antibody Technique, Indirect , Genes, MHC Class I , Genetic Predisposition to Disease , Hair/growth & development , Hair Follicle/growth & development , Immunoglobulin M/analysis , Male , Mice , Species Specificity
5.
Br J Radiol ; 79(942): 522-5, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16714756

ABSTRACT

Endobronchial brachytherapy was developed as effective treatment of endobronchial cancer and fractionated schedule is applied to decrease late toxicity. However, repeated bronchofiberscopy is onerous to the patient and restricts the treatment schedule itself. We applied mini-tracheostomy for a ready access route, and a torque controlled technique for easy insertion of the endobronchial applicator. Eight patients with tracheobronchial cancer invasion were treated with endobronchial brachytherapy of 18-30 Gy/3-5 fractions/1.5-2.5 weeks (median 24 Gy/4 fractions/2 weeks) at reference points of 5 mm from the bronchial surface. The averaged individual irradiation and single session times were 4 min and 24 min, respectively. There were no procedure-related complications. These technical improvements may facilitate flexible fractionated dose prescriptions.


Subject(s)
Brachytherapy/methods , Bronchial Neoplasms/radiotherapy , Tracheal Neoplasms/radiotherapy , Tracheostomy/methods , Aged , Brachytherapy/instrumentation , Dose Fractionation, Radiation , Equipment Design , Female , Humans , Male , Middle Aged , Radiotherapy Dosage , Torque , Treatment Outcome
6.
Clin Exp Immunol ; 136(2): 245-54, 2004 May.
Article in English | MEDLINE | ID: mdl-15086387

ABSTRACT

The anticancer agent 5-fluorouracil (FU) frequently induces cutaneous lupus erythematosus (LE) lesions on sun exposed sites. Based on this observation, we have tried to establish a cutaneous LE model of C57BL/6 J (B6) mice, B6 T cell receptor (TCR)-alpha(-/-) mice and B6 TCR-delta(-/-) mice treated with FU and/or ultraviolet B light (UVBL) in order to clarify the role of T cells and the cytokine profile of cutaneous lupus lesions. Cutaneous LE-like skin lesions could be induced in TCR-alpha(-/-) mice with low FU (0.2 mg) plus UVBL, and in B6 mice treated with a high dose of FU (2.0 mg) plus UVBL. In contrast, low FU plus UVBL induced such skin lesions in TCR-delta(-/-) mice at a very low incidence. Specifically, the skin lesions of TCR-alpha(-/-) mice with low FU plus UVBL appeared more rapidly and were more severe than lesions in B6 mice. The former had the common characteristic features of human chronic cutaneous LE such as typical histology, positive IgG at the dermoepidermal junction, low antinuclear antibody and low mortality. Furthermore, a Th1 response was induced in the development of drug-induced cutaneous LE. FU and UVBL-induced cutaneous LE-like eruption is an excellent model for better understanding the pathomechanisms of skin lesion development in LE.


Subject(s)
Antineoplastic Agents/adverse effects , Fluorouracil/adverse effects , Genes, T-Cell Receptor alpha , Lupus Erythematosus, Cutaneous/immunology , Skin/immunology , Ultraviolet Rays/adverse effects , Animals , Dose-Response Relationship, Drug , Gene Deletion , Genes, T-Cell Receptor delta , Interferon-gamma/immunology , Interleukin-12/immunology , Interleukin-2/immunology , Mice , Mice, Inbred C57BL , Mice, Knockout , Th1 Cells/immunology , Tumor Necrosis Factor-alpha/immunology
7.
Bone Marrow Transplant ; 32(3): 313-6, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12858204

ABSTRACT

Many patients suffer febrile diseases soon after allogeneic stem cell transplantation (SCT). Some of the symptoms of viral infections and acute GVHD are often difficult to distinguish. However, an accurate diagnosis is important since the treatments for these conditions are different. It is known that MxA protein is specifically induced in patients with several viral infections. We investigated the cytoplasmic expression of MxA in the peripheral blood mononuclear cells (PBMCs) of patients with fever after allogeneic SCT using a newly generated monoclonal antibody (KM1135) and flow cytometry. The level of MxA expression was significantly higher in patients diagnosed with viral infections (n=6, cytomegalovirus in three, Epstein-Barr virus in one, human herpesvirus-6 in one, adenovirus in one) than control individuals (n=9) (P<0.05, Mann-Whitney test). The level of MxA in patients with aGVHD (n=7) was identical to that in controls. The level of MxA correlated well with the amount of the cytomegalovirus antigen-positive cells in the presence of acute GVHD in two patients. The measurement of MxA is simple and useful in distinguishing viral disease from acute GVHD after allogeneic SCT.


Subject(s)
GTP-Binding Proteins/analysis , Hematopoietic Stem Cell Transplantation/adverse effects , Virus Diseases/diagnosis , Adolescent , Adult , Antibodies, Monoclonal , Case-Control Studies , Child , Diagnosis, Differential , Female , Fever/etiology , Flow Cytometry , Graft vs Host Disease/diagnosis , Humans , Leukocytes, Mononuclear/chemistry , Male , Middle Aged , Myxovirus Resistance Proteins , Transplantation, Homologous , Virus Diseases/etiology
8.
Bone Marrow Transplant ; 31(12): 1169-71, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12796798

ABSTRACT

The optimal treatment for natural killer (NK) cell leukemia after chronic active Epstein-Barr virus (CAEBV) infection has not been determined. A 15-year-old boy presented with NK cell leukemia following CAEBV infection for 5 years. The peripheral blood and BM had an increased number of CD3(-)CD56(+) large granular lymphocytes and a monoclonal integration of the EBV genome was detected. Chemotherapy was not sufficiently effective to control the disease. Allogeneic BMT from an HLA-identical sister was performed using a conditioning regimen consisting of total body irradiation, cyclophosphamide and thiotepa. The patient is disease-free with a perfect performance status 24 months after BMT. This is the first report to show that allogeneic BMT is potentially able to cure NK cell leukemia after CAEBV infection.


Subject(s)
Bone Marrow Transplantation , Epstein-Barr Virus Infections/complications , Killer Cells, Natural , Leukemia, Lymphoid/etiology , Leukemia, Lymphoid/therapy , Adolescent , DNA, Viral/blood , DNA, Viral/genetics , Herpesvirus 4, Human/genetics , Herpesvirus 4, Human/isolation & purification , Humans , Killer Cells, Natural/virology , Leukemia, Lymphoid/virology , Male , Transplantation, Homologous , Virus Integration
9.
Bone Marrow Transplant ; 30(1): 41-4, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12105776

ABSTRACT

The prognosis for blastic natural killer (NK) cell lymphoma is generally dismal. We report a patient who was successfully treated with unrelated cord blood transplantation (UCBT). A 15-year-old boy was diagnosed as having blastic NK cell lymphoma in the cervical lymph nodes. Autologous peripheral blood stem cell transplantation was performed on achieving a complete remission. However, the disease recurred in the bone marrow 6 months later. Chemotherapy induced a second remission and the patient received UCBT with a conditioning regimen consisting of total body irradiation, thiotepa and cyclophosphamide. Chronic GVHD of the lung occurred, but it was well controlled with steroids. At the time of writing, he remains in remission 18 months after UCBT with an excellent performance status. UCBT may be an option for patients with blastic NK cell lymphoma.


Subject(s)
Blast Crisis/therapy , Cord Blood Stem Cell Transplantation , Killer Cells, Natural/pathology , Lymphoma, T-Cell/therapy , Adolescent , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Disease-Free Survival , Humans , Immunophenotyping , Killer Cells, Natural/immunology , Lymphoma, T-Cell/pathology , Male , Remission Induction/methods
10.
Anticancer Drugs ; 12(9): 731-4, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11593054

ABSTRACT

We describe an extremely rare case of a woman with pulmonary metastatic disease from breast cancer, who presented with features of hypertrophic pulmonary osteoarthropathy (HPOA). Pain associated with HPOA may be extremely disabling and resistant to treatment. Treatment with pamidronate, an inhibitor of osteoclastic bone resorption, given every 2 weeks by i.v. drip infusion, led to rapid disappearance of uncontrolled pain caused by HPOA.


Subject(s)
Breast Neoplasms/pathology , Diphosphonates/therapeutic use , Lung Neoplasms/complications , Lung Neoplasms/secondary , Osteoarthropathy, Secondary Hypertrophic/complications , Pain/drug therapy , Pain/etiology , Palliative Care , Adult , Female , Humans , Pamidronate
11.
Gan To Kagaku Ryoho ; 28(5): 707-10, 2001 May.
Article in Japanese | MEDLINE | ID: mdl-11383223

ABSTRACT

A 56-year-old male patient underwent a right upper lobectomy and lymph node dissection for non-small cell lung cancer in March 1994. Multiple lung metastases in the right lung were found 45 months after the operation, and chemotherapy with docetaxel was administered. A liver metastasis was detected 11 months later, and it was refractory to docetaxel. Therefore, the patient was treated with cisplatin, mitomycin C and vinorelbine, which resulted in no change to the liver metastasis. He was next treated with gemcitabine, which resulted in a partial response of the liver metastasis. The adverse effects of gemcitabine were Grade 3 thrombocytopenia and Grade 2 neutropenia. The response duration for gemcitabine therapy was three months.


Subject(s)
Adenocarcinoma/drug therapy , Adenocarcinoma/secondary , Antimetabolites, Antineoplastic/administration & dosage , Deoxycytidine/administration & dosage , Liver Neoplasms/drug therapy , Liver Neoplasms/secondary , Lung Neoplasms/drug therapy , Lung Neoplasms/pathology , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Deoxycytidine/analogs & derivatives , Drug Administration Schedule , Humans , Male , Middle Aged , Gemcitabine
12.
J Dermatol ; 28(3): 168-71, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11349471

ABSTRACT

We report a 46-year-old Japanese man with a metastatic skin tumor on his left palmar region. He underwent resection for a mediastinal neuroendocrine carcinoma in February of 1998. After the operation, he immediately noticed an elevated tumor on his left palm. In September 1999, a brain tumor was discovered. The skin and brain tumors were subsequently removed surgically. Neuron specific enolase (NSE) in the serum was elevated to 25 ng/ml. A skin biopsy specimen from the left palmar site revealed multiple tumor nests which showed the same histological features as the primary mediastinal tumor. Immunostaining was positive for chromogranin, synaptophysin, and NSE but negative for S-100 protein and CD57. To our knowledge, this is the first report of cutaneous metastasis of a neuroendocrine tumor derived from the mediastinum.


Subject(s)
Carcinoma, Neuroendocrine/diagnosis , Mediastinal Neoplasms/diagnosis , Skin Neoplasms/diagnosis , Carcinoma, Neuroendocrine/pathology , Diagnosis, Differential , Hand , Humans , Male , Mediastinal Neoplasms/pathology , Middle Aged , Skin Neoplasms/secondary
13.
Gan To Kagaku Ryoho ; 28(4): 511-4, 2001 Apr.
Article in Japanese | MEDLINE | ID: mdl-11329786

ABSTRACT

A 73-year-old woman underwent docetaxel therapy for lung metastasis from breast cancer after having received CAF therapy. Because of the progressive disease due to secondary resistance to docetaxel, the patient was given three courses of paclitaxel therapy (60 mg/m2, day 1, 8, 15 and 22, repeated every 6 weeks). The paclitaxel therapy brought about no adverse effects and a 51%-reduction in the size of the metastatic lung tumor (PR). Although the duration of the response to the paclitaxel therapy was limited to about one month due to progression of a brain metastasis, paclitaxel therapy may be effective against docetaxel-resistant breast cancer.


Subject(s)
Antineoplastic Agents, Phytogenic/therapeutic use , Breast Neoplasms/drug therapy , Paclitaxel/analogs & derivatives , Paclitaxel/therapeutic use , Taxoids , Aged , Antineoplastic Agents, Phytogenic/administration & dosage , Brain Neoplasms/secondary , Breast Neoplasms/pathology , Docetaxel , Drug Administration Schedule , Drug Resistance, Neoplasm , Female , Humans , Lung Neoplasms/secondary , Paclitaxel/administration & dosage , Paclitaxel/pharmacology
14.
Bone Marrow Transplant ; 27(7): 767-9, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11360120

ABSTRACT

We describe here the case of an 8-year-old girl with Fanconi anemia (FA) whose hematopoiesis was successfully restored by unrelated umbilical cord blood (UCB) transplantation. The patient became resistant to androgen therapy, and developed intracranial hemorrhage and dyserythropoiesis. Her hematopoietic recovery after the transplantation was excellent and a complete chimerism has been durably maintained. UCB should be considered as a stem cell source for transplantation when a patient with FA does not have an HLA-identical unaffected sibling donor.


Subject(s)
Fanconi Anemia/therapy , Hematopoiesis , Hematopoietic Stem Cell Transplantation , Child, Preschool , Disease-Free Survival , Fanconi Anemia/complications , Female , Fetal Blood , Graft Survival , Histocompatibility , Humans , Intracranial Hemorrhages/etiology , Transplantation Chimera
15.
Eur J Dermatol ; 11(1): 54-7, 2001.
Article in English | MEDLINE | ID: mdl-11174141

ABSTRACT

A mixture of uracil and tegafur (UFT) is a common antineoplastic agent in Japan. We report a 64-year-old Japanese woman with discoid lupus erythematosus (DLE)-like lesions which were induced by UFT. After surgery to treat lung cancer, UFT (300 mg/day) was administered and she developed round erythema on her right cheek. A skin biopsy specimen taken from the right cheek site revealed atrophy of the epidermis, a slight liquefaction of the basal cell layer, and patchy lymphocytic infiltration in the perivascular and perifollicular regions. A test for antinuclear antibody was weakly positive (80 fold), and rheumatoid factor was slightly elevated (7.6 IU/ml). After discontinuation of UFT, the erythema completely regressed within 2 months. We reviewed 17 cases of DLE-like lesions induced by fluorouracil agents and summarized the common features.


Subject(s)
Antimetabolites, Antineoplastic/adverse effects , Drug Eruptions/diagnosis , Facial Dermatoses/diagnosis , Lung Neoplasms/drug therapy , Tegafur/adverse effects , Uracil/adverse effects , Cheek , Chemotherapy, Adjuvant , Diagnosis, Differential , Drug Eruptions/etiology , Drug Eruptions/pathology , Facial Dermatoses/chemically induced , Facial Dermatoses/pathology , Female , Humans , Lung Neoplasms/surgery , Lupus Erythematosus, Discoid/diagnosis , Middle Aged
16.
Anticancer Res ; 21(6A): 4083-6, 2001.
Article in English | MEDLINE | ID: mdl-11911296

ABSTRACT

Recurrent breast cancer has a very poor response rate to chemotherapy. To understand the degree of acquisition of multidrug resistance in recurrent disease, 24 recurrent breast tumors and 127 primary tumors were evaluated and compared for chemosensitivity in the histoculture drug response assay (HDRA). The evaluation rate was 98.8%. The HDRA utilizes 3-dimensional culture of human tumors on collagen-gel rafts. Doxorubicin (DXR), 5-fluorouracil (5-FU) and mitomycin C (MMC) were tested as standard agents and cisplatin (CDDP) as a candidate agent on surgical specimen of breast cancer in the HDRA. In vitro drug exposure in the HDRA was for 7 days. At the end of the assay, tumor response was assessed by the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). The mean inhibition rates of primary tumors vs. recurrent tumors were 57.9% and 38.6% for DXR (p<0.0005); 59.9% and 42.8% for MMC (p<0.01); 49.0% and 33.4% for 5-FU (p<0.01); and 34.5% and 16.0% for CDDP (p<0.005), respectively. The recurrent cases were pretreated clinically with CAF (cyclophosphamide, DXR and 5-FU), CEF (cyclophosphamide, epirubicin and 5-FU) or CMF (cyclophosphamide, methotrexate and 5-FU). In the CAF and CEF group, the HDRA sensitivity to CDDP was significantly lower in recurrent disease (p<0.005) than that of primary breast cancer suggesting that one agent can induce resistance to another. This is further suggested by the fact that 64.7% of the recurrent cases were resistant to all 4 agents tested as opposed to 27% of the primary cases and that only 5.9% of the recurrent cases were sensitive to three or more agents as opposed to 18% of the primary cases. The correlation of the HDRA results to clinical outcome in the study was 80.0% with 15 cases evaluated consisting of 5 true positives, 3 false positives, 7 true negatives and no false negatives. Thus, the HDRA gives useful clinical information, in particular for the specific individualized treatment design necessary to overcome the multidrug resistance problem of recurrent breast cancer.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms, Male/drug therapy , Breast Neoplasms/drug therapy , Drug Resistance, Multiple , Neoplasm Recurrence, Local/drug therapy , Adult , Aged , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Breast Neoplasms/pathology , Breast Neoplasms, Male/pathology , Cyclophosphamide/administration & dosage , Doxorubicin/administration & dosage , Drug Resistance, Neoplasm , Drug Screening Assays, Antitumor , Epirubicin/administration & dosage , Female , Fluorouracil/administration & dosage , Humans , Male , Methotrexate/administration & dosage , Middle Aged , Neoplasm Staging
17.
J Neurosurg ; 95(2): 275-84, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11780898

ABSTRACT

OBJECT: There is growing evidence to indicate that tissue transplantation can potentially be a restorative neurosurgical treatment for patients with Parkinson disease (PD). In this study the authors investigated the clinical effect of unilateral intrastriatal grafting of autologous sympathetic neurons in patients with PD. METHODS: Four patients with PD who had been observed for 1 year after graft placement of autologous sympathetic neurons were selected for an analysis of the effect of that procedure. Sympathetic ganglion tissue was endoscopically excised from the thoracic sympathetic trunk and grafted into the unilateral caudate head and putamen of the PD patients. No changes were made in the patients' preoperative regimens of antiparkinsonian medications, and clinical evaluations were made principally according to those established by the Core Assessment Program for Intracerebral Transplantation Committee. Whereas the sympathetic neuron grafts failed to affect clinical scores reflecting the patients' motor performance, which was evaluated during either the "on" or "off' phases, the grafts significantly increased the duration of the levodopa-induced on period with consequent reduction in the percentage of time spent in the off phase. This beneficial effect may be explained by the results of the present in vitro experiment, which show that human sympathetic neurons have the ability to convert exogenous levodopa to dopamine and to store this synthesized dopamine. CONCLUSIONS: Sympathetic neuron autografts were found to improve performance status in patients with PD by reducing the time spent in the off phase. This clearly indicates that sympathetic ganglion tissue, the use of which involves few ethical issues, can be an efficacious donor source in cell transplantation therapy for PD. Further studies are needed to determine whether the grafts may provide long-lasting clinical benefits.


Subject(s)
Antiparkinson Agents/pharmacology , Antiparkinson Agents/therapeutic use , Ganglia, Sympathetic/transplantation , Levodopa/pharmacology , Levodopa/therapeutic use , Neurons/transplantation , Parkinson Disease/drug therapy , Parkinson Disease/surgery , Catecholamines/biosynthesis , Caudate Nucleus/surgery , Female , Follow-Up Studies , Ganglia, Sympathetic/drug effects , Ganglia, Sympathetic/physiopathology , Humans , In Vitro Techniques , Male , Middle Aged , Neurons/drug effects , Neurons/physiology , Parkinson Disease/physiopathology , Psychomotor Performance/drug effects , Psychomotor Performance/physiology , Putamen/surgery , Stereotaxic Techniques , Transplantation, Autologous , Treatment Outcome
18.
Breast Cancer ; 7(4): 307-10, 2000.
Article in English | MEDLINE | ID: mdl-11114855

ABSTRACT

BACKGROUND: We evaluated the usefulness of bisphosphonate (BIS) monotherapy, the safety of rapid infusion of BIS and the efficacy of BIS-sequential therapy for bone metastases from breast cancer. PATIENTS AND METHODS: Twenty-nine patients with bone metastasis or invasion were treated with BIS monotherapy. Each BIS (pamidronate 30 mg, alendronate 10 mg, or incadronate 10 mg) was infused over 30 minutes every two weeks a median of 12 times. RESULTS: With BIS therapy, five patients (17%) showed partial response of the bone lesions, and eighteen patients (64%) had pain relief. Of the nine patients treated with BIS-sequential therapy, one (11%) showed a partial response of the bone metastases, three (33%) had pain relief, and one (11%) showed a decrease in the serum tumor marker level. CONCLUSION: BIS therapy is effective against bone metastases from breast cancer, and rapid infusion of BIS is both safe and convenient for patients. BIS-sequential therapy can be a unique therapeutic option in some cases.


Subject(s)
Bone Neoplasms/drug therapy , Bone Neoplasms/secondary , Breast Neoplasms/drug therapy , Diphosphonates/therapeutic use , Adult , Aged , Breast Neoplasms/pathology , Female , Humans , Middle Aged
19.
Bone Marrow Transplant ; 26(8): 907-10, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11081394

ABSTRACT

We report a 13-year-old boy who developed dyspnea at rest 1 year after the occurrence of cGVHD following an allogeneic bone marrow transplant (BMT). Pulmonary function data, imaging studies, lung biopsy, and bronchoalveolar lavage were consistent with the diagnosis of bronchiolitis obliterans organizing pneumonia (BOOP). Although reports suggest that oral methylprednisolone or methylprednisolone pulse therapies improve BOOP after BMT, we treated our patient with a combination of oral prednisolone (1 mg/kg) and low dose erythromycin (10 mg/kg) to avoid the side-effects of high-dose steroids. With this therapy, our patient showed clinical and radiological improvements within 1 week. The steroids were tapered off 12 months later and erythromycin was given for 14 months. We conclude that therapy consisting of a combination of oral prednisolone and low-dose erythromycin for BOOP after BMT may minimize the dose and duration of steroid use.


Subject(s)
Bone Marrow Transplantation/adverse effects , Cryptogenic Organizing Pneumonia/drug therapy , Erythromycin/administration & dosage , Prednisolone/administration & dosage , Administration, Oral , Adolescent , Cryptogenic Organizing Pneumonia/etiology , Drug Therapy, Combination , Graft vs Host Disease/etiology , Humans , Male , Transplantation, Homologous
20.
Kyobu Geka ; 53(10): 831-3, 2000 Sep.
Article in Japanese | MEDLINE | ID: mdl-10998860

ABSTRACT

We performed a operation using a mini mid-line skin incision for ten-year-old male with funnel chest. The skin incision was made from the level of nipple to the lower end of the xiphoid process. He had sternal elevation as corrective surgery. There was no complication and he discharged at 11th day after surgery. We believe our method is more appropriate in fulfilling the cosmetic needs for the patient of funnel chest.


Subject(s)
Dermatologic Surgical Procedures , Funnel Chest/surgery , Plastic Surgery Procedures/methods , Child , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...